COVID-19 and Drug Policy Discussion Series

How does COVID-19 exacerbate the pre-existing conditions of the drug war?

People who use drugs are especially impacted by policing, surveillance, and criminalization. COVID-19 both highlights and brings to the forefront the state-imposed punishment of people who use drugs.

The Drug Policy Alliance is hosting a series of seven online discussions about COVID-19 and drug policy. These discussions bring together advocates and allies in the justice reform and harm reduction movements to discuss how we can sustain progress, which obstacles still remain, and how we can use the current moment to be more aspirational with our policy agendas.

Join Us for the Next Discussion

June 11, 2-4 PM ET - Improving Substance Use Disorder Treatment During and After the COVID-19 Pandemic
Access to effective substance use disorder (SUD) treatment has long been out of reach for many. The COVID-19 pandemic has forced treatment providers and clients to limit in-person interaction, reducing longstanding barriers to treatment for some, but increasing challenges for others. Join advocates and allies in the drug policy reform and treatment movements to assess what changes have occurred and how positive reforms can be maintained while addressing remaining challenges to SUD treatment during and after the pandemic. Register to attend.

Mark your calendar for more in this online discussion series.

Watch the recordings of previous discussions below.


05/20/20
Reconsidering Reentry: Exploring Decarceration in its Fullness Amid COVID-19

Federal and state policies distinctly prohibit supports for people who are struggling with addiction and/or are drug involved. In the era of COVID-19 and beyond, calls for decarceration need to be coupled with urgent… Read More

05/07/20
COVID-19, Drug Policy, and Decarceration: Reflections and Looking Ahead

How does decarceration support ending the drug war? How do both decarceration and the decriminalization of drugs support the health and safety of people who use drugs? COVID-19 both highlights and brings to the forefront… Read More